A
Andrey Shuldyakov
Publications - 4
Citations - 450
Andrey Shuldyakov is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 401 citations.
Papers
More filters
Journal ArticleDOI
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.
Pedro Cahn,Anton Pozniak,Horacio Mingrone,Andrey Shuldyakov,Carlos Brites,Jaime Andrade-Villanueva,Gary Richmond,Carlos Beltran Buendia,Jan Fourie,Moti Ramgopal,Debbie Hagins,Franco Felizarta,José Valdez Madruga,Tania Reuter,Tamara Newman,Catherine B. Small,John Lombaard,Beatriz Grinsztejn,David Dorey,Mark R. Underwood,Sandy Griffith,Sherene Min +21 more
TL;DR: Once-daily dolutegravir, in combination with up to two other antiretroviral drugs, is well tolerated with greater virological effect compared with twice-daily raltegravIR in this treatment-experienced patient group.
Journal ArticleDOI
Infections, Pandemics, and Sleep Disorders
TL;DR: In this article , the factors and mechanisms of sleep impairments and their relationship with inflammation and immune system dysfunction in infectious diseases are discussed as the cause of sleeplessness during pandemics.
Journal ArticleDOI
Metabolic support of antiviral therapy in patients with COVID-19
TL;DR: The use of the corrector of cellular and energy metabolism metabolism Remaxol as a hepatoprotector in complex therapy contributes to favorable clinical dynamics, stabilization of biochemical parameters of liver function and allows completing the course of etiotropic therapy in all patients.